Dr. Sinead Mellett's Natural Vet Company: A Holistic Approach to Pet Health

Dr. Sinead Mellett, a veterinarian with over a decade of experience in companion animal practice across Ireland, Canada, New Zealand, and Australia, has launched the Natural Vet Company to address chronic health issues in pets, such as skin and digestive problems. Frustrated by the limitations of conventional treatments, Mellett began studying veterinary herbal medicine, leading to the creation of her start-up in 2022, which officially launched in late 2024. The company aims to provide safe, effective, and natural alternatives for pet health, bridging the gap between traditional veterinary medicine and herbal care.

The Irish Times

The Natural Vet Company offers a range of herbal and marine-based products designed to support long-term health in cats and dogs. The current lineup includes seven products targeting skin, coat, digestion, and joint health, with plans for additional offerings, such as a natural tick and flea repellent. Mellett emphasizes that skin issues account for a significant portion of veterinary consultations, while arthritis is common in older animals. One notable product, Calm, is designed to help pets manage anxiety without heavy sedation, promoting gentle nervous system regulation.

The Irish Times

Mellett's motivation for developing her products stems from her observations of the overuse of steroids, antibiotics, and non-steroidal anti-inflammatories in veterinary practice. She advocates for a holistic approach that focuses on identifying the root causes of diseases rather than merely treating symptoms. This philosophy is reflected in her formulations, which are based on clinical experience and evidence-informed research. Mellett highlights the importance of using premium-grade, sustainably sourced ingredients administered at correct therapeutic doses.

The Irish Times

The Natural Vet Company sells its products online and through an expanding network of retailers, with plans to target veterinary practices. Mellett acknowledges the need to educate fellow veterinarians about the benefits of natural remedies. In addition to her venture, her husband, Eoghan O’Connor, operates Home Vetcare, a mobile clinic for small animals. Despite the challenges of starting a manufacturing business in Ireland, including high overhead costs, Mellett has invested approximately €75,000 into her company and remains committed to maintaining product quality.

The Irish Times

Having recently entered the UK market, Mellett is now focused on expanding into the European Union. She aims to scale the Natural Vet Company significantly while building a solid market presence. After two years of hard work, Mellett has begun to draw a salary from her business, although she occasionally misses the clinical aspects of her previous veterinary role. The transition to self-employment has presented its own set of challenges, but Mellett's dedication to improving pet health through holistic solutions remains unwavering.

The Irish Times

• “I am passionate about bridging the gap between traditional veterinary medicine and herbal care, providing safe, effective, and natural options for cats and dogs, while empowering their owners with the choice of integrative health support,” — Dr. Sinead Mellett, Founder, Natural Vet Company

The Irish Times

• “The holistic approach involves a different kind of medical assessment of patients as we look at the root cause of disease rather than repetitively treating the presenting symptoms.” — Dr. Sinead Mellett

The Irish Times

• “Sometimes I miss clinical work, especially the surgical side of things, and there are days when everything seems to be an uphill battle. Adjusting to self-employment after spending the previous decade in employment has also brought its own challenges.” — Dr. Sinead Mellett

The Irish Times

While Mellett's approach has garnered support, there are concerns regarding the efficacy and regulation of herbal remedies in veterinary medicine. Critics may question the scientific backing of herbal treatments compared to established pharmaceutical options, highlighting the need for further research and validation in this emerging field.

The Irish Times